BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,657,756 | +37.5% | 484,730 | +82.6% | 0.00% | +100.0% |
| Q2 2023 | $8,477,575 | -46.9% | 265,505 | -49.1% | 0.00% | -75.0% |
| Q1 2023 | $15,963,951 | +80.3% | 521,357 | +130.3% | 0.00% | +33.3% |
| Q4 2022 | $8,852,353 | -64.0% | 226,345 | -56.2% | 0.00% | -57.1% |
| Q3 2022 | $24,610,000 | +74.7% | 516,590 | +42.0% | 0.01% | +75.0% |
| Q2 2022 | $14,083,000 | -30.4% | 363,802 | +3.1% | 0.00% | +33.3% |
| Q1 2022 | $20,225,000 | -58.5% | 352,968 | -42.3% | 0.00% | +200.0% |
| Q4 2021 | $48,764,000 | +78.5% | 611,912 | +94.9% | 0.00% | -75.0% |
| Q3 2021 | $27,312,000 | -36.2% | 313,886 | -5.7% | 0.00% | -33.3% |
| Q2 2021 | $42,837,000 | +18.3% | 332,818 | -26.5% | 0.01% | 0.0% |
| Q1 2021 | $36,223,000 | -8.1% | 452,557 | -6.3% | 0.01% | +100.0% |
| Q4 2020 | $39,432,000 | – | 483,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |